VA SB271 | 2026 | Regular Regular Session
Status
Sponsorship: Partisan Bill (Democrat 2)
Status: Vetoed on May 19 2026 - 100% progression
Action: 2026-05-19 - Vetoed by Governor
Text: Latest bill text (Comm Sub) [HTML]
Status: Vetoed on May 19 2026 - 100% progression
Action: 2026-05-19 - Vetoed by Governor
Text: Latest bill text (Comm Sub) [HTML]
Summary
Prescription Drug Affordability Advisory Panel established; maximum fair price; annual reports; civil penalties. Directs the Secretary of Health and Human Resources to establish the Prescription Drug Affordability Advisory Panel to conduct data analyses, develop policy recommendations, and identify implementation barriers related to strategies to improve prescription drug affordability, enhance price transparency, and strengthen data collection practices for prescription drugs across public and private payers. The bill requires the Panel to (i) report annually on prescription drug pricing trends and any policy recommendations on legislation to improve prescription drug affordability and (ii) provide quarterly updates on prescription drug pricing trends. The bill requires each pharmacy benefits manager to provide to the Panel, upon request, certain information relating to the dispensation of a referenced drug, as defined in the bill.The bill prohibits prescription drug manufacturers or wholesale distributors permitted or licensed in the Commonwealth from accepting payment at an amount higher than the maximum fair price established by the U.S. Secretary of Health and Human Services pursuant to federal law for the sale of a referenced drug intended for use by individuals in the Commonwealth. Under the bill, an entity that violates such prohibition is subject to a civil penalty of $10,000 per violation. The bill also prohibits a manufacturer subject to its provisions from removing a referenced drug from sale distribution in the Commonwealth for the purpose of avoiding the impact of the bill's rate limitations without providing certain prior notice. Under the bill, a manufacturer that violates such prohibition on removing a referenced drug without the required notice is subject to a civil penalty equal to the greater of $100,000 or the total amount of annual savings for the referenced drug, as determined by the Board of Pharmacy. This bill is identical to HB 483.
Title
Prescription Drug Affordability Board; established.
Sponsors
Roll Calls
2026-03-11 - Senate - House substitute agreed to by Senate (32-Y 8-N 0-A) (Y: 32 N: 8 NV: 0 Abs: 0) [PASS]
2026-03-10 - House - Passed House with substitute (95-Y 4-N 0-A) (Y: 95 N: 4 NV: 0 Abs: 0) [PASS]
2026-03-04 - House - Reported from Appropriations (17-Y 5-N) (Y: 17 N: 5 NV: 0 Abs: 0) [PASS]
2026-02-06 - Senate - Read third time and passed Senate (31-Y 8-N 0-A) (Y: 31 N: 8 NV: 0 Abs: 1) [PASS]
2026-02-04 - Senate - Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A) (Y: 40 N: 0 NV: 0 Abs: 0) [PASS]
2026-02-03 - Senate - Reported from Finance and Appropriations (9-Y 5-N 1-A) (Y: 9 N: 5 NV: 1 Abs: 0) [PASS]
2026-01-26 - Senate - Reported from Commerce and Labor with amendments and rereferred to Finance and Appropriations (10-Y 4-N 1-A) (Y: 10 N: 4 NV: 1 Abs: 0) [PASS]
2026-01-22 - Senate - Rereferred from Education and Health to Commerce and Labor (14-Y 0-N) (Y: 14 N: 0 NV: 0 Abs: 1) [PASS]
2026-03-10 - House - Passed House with substitute (95-Y 4-N 0-A) (Y: 95 N: 4 NV: 0 Abs: 0) [PASS]
2026-03-04 - House - Reported from Appropriations (17-Y 5-N) (Y: 17 N: 5 NV: 0 Abs: 0) [PASS]
2026-02-06 - Senate - Read third time and passed Senate (31-Y 8-N 0-A) (Y: 31 N: 8 NV: 0 Abs: 1) [PASS]
2026-02-04 - Senate - Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A) (Y: 40 N: 0 NV: 0 Abs: 0) [PASS]
2026-02-03 - Senate - Reported from Finance and Appropriations (9-Y 5-N 1-A) (Y: 9 N: 5 NV: 1 Abs: 0) [PASS]
2026-01-26 - Senate - Reported from Commerce and Labor with amendments and rereferred to Finance and Appropriations (10-Y 4-N 1-A) (Y: 10 N: 4 NV: 1 Abs: 0) [PASS]
2026-01-22 - Senate - Rereferred from Education and Health to Commerce and Labor (14-Y 0-N) (Y: 14 N: 0 NV: 0 Abs: 1) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2026-05-19 | Vetoed by Governor | |
| 2026-05-19 | Senate | Governor's Veto Received by Senate |
| 2026-04-22 | Governor's Action Deadline 11:59 p.m., May 23, 2026 | |
| 2026-04-22 | Senate | Communicated to Governor |
| 2026-04-22 | Senate | Passed by for the day (Voice Vote) |
| 2026-04-13 | Governor's recommendation received by Senate | |
| 2026-03-31 | Governor's Action Deadline 11:59 p.m., April 13, 2026 | |
| 2026-03-31 | Senate | Enrolled Bill communicated to Governor on March 31, 2026 |
| 2026-03-31 | House | Signed by Speaker |
| 2026-03-31 | Senate | Fiscal Impact Statement from Department of Planning and Budget (SB271) |
| 2026-03-30 | Senate | Signed by President |
| 2026-03-30 | Senate | Bill text as passed Senate and House (SB271ER) |
| 2026-03-30 | Senate | Enrolled |
| 2026-03-23 | Senate | Fiscal Impact Statement from Department of Planning and Budget (SB271) |
| 2026-03-11 | Senate | House substitute agreed to by Senate |
| 2026-03-10 | House | Passed House with substitute (95-Y 4-N 0-A) |
| 2026-03-10 | House | Engrossed by House - floor substitute |
| 2026-03-10 | House | Delegate Delaney Floor substitute agreed to |
| 2026-03-10 | House | Delegate Delaney Floor amendments withdrawn |
| 2026-03-10 | House | Delegate Delaney Substitute withdrawn by House |
| 2026-03-10 | House | Read third time |
| 2026-03-10 | House | Floor offered Delegate Delaney Substitute |
| 2026-03-10 | House | Floor substitute printed 26109555D-H2 (Delaney) |
| 2026-03-09 | House | Passed by for the day |
| 2026-03-09 | House | Passed by temporarily |
| 2026-03-09 | House | Read third time |
| 2026-03-09 | House | Floor offered Delegate Delaney Amendments |
| 2026-03-09 | House | Floor offered Delegate Delaney Substitute |
| 2026-03-09 | House | Floor substitute printed 26109393D-H1 (Delaney) |
| 2026-03-06 | House | Read second time |
| 2026-03-04 | House | Reported from Appropriations (17-Y 5-N) |
| 2026-02-12 | House | Referred to Committee on Appropriations |
| 2026-02-12 | House | Read first time |
| 2026-02-12 | House | Placed on Calendar |
| 2026-02-11 | House | Assigned HAPP sub: Health & Human Resources |
| 2026-02-10 | Senate | Fiscal Impact Statement from Department of Planning and Budget (SB271) |
| 2026-02-06 | Senate | Read third time and passed Senate (31-Y 8-N 0-A) |
| 2026-02-05 | Senate | Engrossed by Senate as amended (Voice Vote) |
| 2026-02-05 | Senate | Commerce and Labor Amendments agreed to |
| 2026-02-05 | Senate | Read second time |
| 2026-02-04 | Senate | Passed by for the day Block Vote (Voice Vote) |
| 2026-02-04 | Senate | Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A) |
| 2026-02-04 | Senate | Rules suspended |
| 2026-02-03 | Senate | Reported from Finance and Appropriations (9-Y 5-N 1-A) |
| 2026-01-27 | Senate | Fiscal Impact Statement from Department of Planning and Budget (SB271) |
| 2026-01-26 | Senate | Reported from Commerce and Labor with amendments and rereferred to Finance and Appropriations (10-Y 4-N 1-A) |
| 2026-01-26 | Senate | Senate committee offered |
| 2026-01-22 | Senate | Rereferred from Education and Health to Commerce and Labor (14-Y 0-N) |
| 2026-01-12 | Senate | Referred to Committee on Education and Health |
| 2026-01-12 | Senate | Prefiled and ordered printed; Offered 01-14-2026 26105318D |
